Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-7-26
pubmed:abstractText
Aminoglycoside (AG) antibiotics are associated with several side effects, including a reversible nephrotoxicity and a permanent ototoxicity. Oxidative stress is thought to contribute to the pathophysiology of both conditions. We studied the possible protective effect of the antioxidant N-acetylcysteine (NAC) in gentamicin-induced hearing loss in hemodialysis patients. This study includes 53 hemodialysis patients scheduled to receive gentamicin for dialysis catheter-related bacteremia that were randomized to receive the antibiotic with or without NAC. Hearing function was assessed by the standard technique of pure-tone audiograms over a range of frequencies. Audiometric evaluations were performed at baseline, 1 week and at 6 weeks after the completion of gentamicin therapy. A total of 40 patients completed the study protocol with a mean duration of therapy of almost 15 days. At both 1 and 6 weeks after the completion of antibiotic therapy, there were significantly more patients exhibiting ototoxicity in the control group compared with the group receiving NAC. Additionally, significantly more patients in the control group had bilateral ototoxicity. The greatest otoprotective effect of NAC was noticed in the high audiometric tone frequencies. Taken together, our study suggests that NAC treatment may ameliorate gentamicin-induced ototoxicity in hemodialysis patients.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0085-2538
pubmed:author
pubmed:issnType
Print
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
359-63
pubmed:meshHeading
pubmed-meshheading:17457375-Acetylcysteine, pubmed-meshheading:17457375-Administration, Oral, pubmed-meshheading:17457375-Aged, pubmed-meshheading:17457375-Aminoglycosides, pubmed-meshheading:17457375-Anti-Bacterial Agents, pubmed-meshheading:17457375-Antioxidants, pubmed-meshheading:17457375-Bacteremia, pubmed-meshheading:17457375-Cysteine, pubmed-meshheading:17457375-Female, pubmed-meshheading:17457375-Gentamicins, pubmed-meshheading:17457375-Glutathione, pubmed-meshheading:17457375-Hearing Loss, pubmed-meshheading:17457375-Humans, pubmed-meshheading:17457375-Kidney Failure, Chronic, pubmed-meshheading:17457375-Male, pubmed-meshheading:17457375-Middle Aged, pubmed-meshheading:17457375-Oxidative Stress, pubmed-meshheading:17457375-Prospective Studies, pubmed-meshheading:17457375-Renal Dialysis
pubmed:year
2007
pubmed:articleTitle
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.
pubmed:affiliation
Nephrology Division, Assaf Harofeh Medical Center, Zerifin, Israel. leonidf@asaf.health.gov
pubmed:publicationType
Journal Article, Randomized Controlled Trial